EcoR1 Capital’s BeOne Medicines Ltd ONC Stock Holding History

EcoR1 Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-83,667	Closed	-$8.18M	–	37
2017 Q4	$8.18M	Buy	83,667 +73,867	+754%	+$6.76M	0.92%	19
2017 Q3	$1.01M	Buy	+9,800	New	+$730K	0.13%	37
2016 Q4	–	Sell	-163,470	Closed	-$5.04M	–	38
2016 Q3	$5.04M	Sell	163,470 -11,910	-7%	-$346K	1.55%	19
2016 Q2	$5.23M	Buy	175,380 +159,614	+1,012%	+$4.68M	2.06%	17
2016 Q1	$462K	Buy	+15,766	New	+$447K	0.16%	33

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

EcoR1 Capital's ONC Position: Q1 2018 in Review

EcoR1 Capital sold out of BeOne Medicines Ltd (ONC) in Q1 2018, closing a stake of 83,667 shares — an estimated $8.18M sold.

EcoR1 Capital first reported a position in ONC in Q1 2016 and held it in 5 quarters. The position peaked at $8.18M in Q4 2017. 123 funds tracked by Wall St. Rank hold ONC as of Q1 2018.

EcoR1 Capital reported no remaining BeOne Medicines Ltd position as of Q1 2018 after selling out during the quarter.
EcoR1 Capital sold 83,667 BeOne Medicines Ltd shares in Q1 2018, an estimated $8.18M.
EcoR1 Capital first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 5 quarters.
EcoR1 Capital's BeOne Medicines Ltd position peaked at $8.18M in Q4 2017.
123 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2018.

Based on EcoR1 Capital's 13F filing for Q1 2018, filed 15 May 2018.